Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Chonbuk National University Hospital
With
Otsuka Pharmaceutical Co., Ltd.
The aim of this study is to investigate the effectiveness of Aripiprazole long-acting injection in recent onset and chronic schizophrenia patients
Age
19–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients diagnosed with schizophrenia according to DSM-5 diagnostic standards
men and women aged 19 and under 60
a person who is being given an atypical antipsychotic.
Patients should be able to reasonably cooperate with the questionnaire to be used for the study
a person who fully understands the purpose of the study and signs the consent
stable outpatient before screening without changing the volume of antipsychotics for at least two weeks
You may not be if
a person who has a serious and unstable physical condition either now or in the past
A fertile woman who is currently pregnant or breastfeeding, or who is either unwilling or unable to use acceptable contraception until the clinical trial is complete.
a person suffering from severe drug allergies or complex and severe drug reactions
Patients who have taken clozapine in the last 60 days
subjects showing significant risk of suicide or significant risk of violent behavior based on past history or investigator's judgment
Clareo Health | Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients
